DanielaAnnenelieBotaMDPhD

Clinical Trials

• Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer Start of enrollment: 2006 Dec 01

  Active, not recruiting

  Phase 3

• Neurological Surgery & Affiliated Services De-Identified Clinical Outcomes Database Start of enrollment: 2005 Aug 04

  Completed

• Liposomal Cytarabine and High-Dose Methotrexate in Treating Patients With Central Nervous System Metastases From Breast Cancer Start of enrollment: 2011 Apr 01

  Completed

  Phase 2

• A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma Start of enrollment: 2011 Dec 01

  Completed

  Phase 2

• ERC1671/GM-CSF/Cyclophosphamide for the Treatment of Glioblastoma Multiforme Start of enrollment: 2014 Mar 01

  Active, not recruiting

  Phase 2

• The Toca 5 Trial: Toca 511 & Toca FC Versus Standard of Care in Patients With Recurrent High Grade Glioma Start of enrollment: 2015 Nov 30

  Terminated

  Phase 2, Phase 3

• Study Of NOVOTTF-200A In Bevacizumab-Naive Subjects With Recurrent Grade III Malignant Astrocytoma Start of enrollment: 2020 May 21

  Active, not recruiting

  Not Applicable

• Pilot Study of Mirtazapine for the Dual Tx of Depression and CINV in High-Grade Glioma Pts on TMZ Start of enrollment: 2019 Feb 26

  Active, not recruiting

  Phase 2

• Effect of NAC on Preventing Chemo-Related Cognitive Impairments in Ovarian Ca Pts Treated W/ PBT Start of enrollment: 2024 Dec 01

  Not yet recruiting

  Phase 1, Phase 2

• Immune Checkpoint Inhibitor Nivolumab in People With Recurrent Select Rare CNS Cancers Start of enrollment: 2017 Jul 13

  Recruiting

  Phase 2

  Roles: Contact

• Join now to see all